Amwise Diagnostic Company
Amwise Diagnostic is a leader in precision medicine technology for cancer. Our patented genetic analysis technologies assist doctors and patients in determining the most appropriate individualized treatment strategy that has optimal treatment effectiveness and minimal treatment-related adverse events.
%20.jpg)
%20.jpg)
Technology:
diagnostics
Headquarters:
Taipei, T'ai-pei, Taiwan
Last Funding Date:
2020-02-26
Total Funding:
$10M
Last Funding Type:
Series B
Founded Date:
2015-01-01
Investors Number:
4
Industry:
Biotechnology, Health Care, Life Science
Employee Number:
11-50
Estimated Revenue:
$1M to $10M
Funding Status:
Early Stage Venture